Novo Nordisk to Operate as Novo Following Corporate Name Change
The latest in this situation
- KAIMRC signed clinical-trial capability partnership with Novo Nordisk and an AI research partnership with Rutgers University.
- Novo Nordisk is undergoing strategic shifts, including rebranding to Novo, appointing a Special Envoy for Health Resilience, and partnering with Cradle for AI-powered protein design.
How it started
What happened
Novo Nordisk announced it will remove 'Nordisk' from its company name, meaning the company will operate as Novo. This change ends a naming convention that has been in place since the 1989 merger of Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium. The company is also refreshing its brand, including its logo, color palette, and typography. Concurrently, Dr. Vanessa Kerry was appointed as the World Health Organization Director-General’s Special Envoy for Health Resilience.
Why it matters
The corporate pivot reflects the company's stated view that consumers want to engage with health in new ways. The appointment of Dr. Kerry expands her role to advocate for resilient and sustainably financed health systems globally. This signals a major strategic shift for the company amidst global health challenges.
Who's involved
- Novo NordiskDanish pharmaceutical company undergoing corporate restructuring and brand refresh.
- World Health OrganizationUnited Nations agency that has appointed a special envoy focused on global health resilience.
How it developed
Newest first. Tap a step to see who reported it.- KAIMRC signed clinical-trial capability partnership with Novo Nordisk and an AI research partnership with Rutgers University.Sub-event
Novo Nordisk announces corporate restructuring, a new strategic partnership with Cradle, and a leadership appointment.1 source